Raltegravir and Warm type haemolytic anaemia - a phase IV clinical study of FDA data
Warm type haemolytic anaemia is reported only by a few people who take Raltegravir.
The phase IV clinical study analyzes which people take Raltegravir and have Warm type haemolytic anaemia. It is created by eHealthMe based on reports of 4,255 people who have side effects while taking Raltegravir from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
4,255 people reported to have side effects when taking Raltegravir.
Among them, 1 person (0.02%) has Warm type haemolytic anaemia.
What is Raltegravir?
Raltegravir has active ingredients of raltegravir. eHealthMe is studying from 4,258 Raltegravir users for its effectiveness, alternative drugs and more.
What is Warm type haemolytic anaemia?
Warm type haemolytic anaemia (red cell destruction due to warm antibody self defence) is found to be associated with 176 drugs and 122 conditions by eHealthMe.
Number of Raltegravir and Warm type haemolytic anaemia reports submitted per year:
Gender of people who have Warm type haemolytic anaemia when taking Raltegravir *:
- female: 100 %
- male: 0.0 %
Age of people who have Warm type haemolytic anaemia when taking Raltegravir *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 100 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 0.0 %
Common side effects people have besides Warm type haemolytic anaemia *:
- Hypergammaglobulinaemia (elevated levels of gamma globulin): 1 person, 100.00%
- Chronic Thyroiditis (long lasting inflammation of thyroid gland): 1 person, 100.00%
- Autoimmune Hepatitis: 1 person, 100.00%
Common conditions people have *:
- Hiv Infection: 1 person, 100.00%
* Approximation only. Some reports may have incomplete information.
Do you take Raltegravir and have Warm type haemolytic anaemia?Check whether Warm type haemolytic anaemia is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Warm type haemolytic anaemia and when was it recovered:
Expand to all the drugs that have ingredients of raltegravir:
Alternative drugs to, pros and cons of Raltegravir:
- Raltegravir (4,258 reports)
Common Raltegravir side effects:
- Depression: 331 reports
- Drug ineffective: 161 reports
- Fever: 135 reports
- Fatigue (feeling of tiredness): 134 reports
- Death: 133 reports
Browse all side effects of Raltegravir:a b c d e f g h i j k l m n o p q r s t u v w x y z
Warm type haemolytic anaemia treatments and more:
- Warm type haemolytic anaemia (205 reports)
COVID vaccines that are related to Warm type haemolytic anaemia:
- Warm type haemolytic anaemia in Moderna COVID Vaccine
- Warm type haemolytic anaemia in Pfizer BioNTech Covid Vaccine
- Warm type haemolytic anaemia in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Warm type haemolytic anaemia:
- Warm type haemolytic anaemia (176 drugs)
All the conditions that are associated with Warm type haemolytic anaemia:
- Warm type haemolytic anaemia (122 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on raltegravir (the active ingredients of Raltegravir) and Raltegravir (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Advil and Erosive Oesophagitis - 18 seconds ago
- Alprostadil and Hypoaesthesia Tongue - 54 seconds ago
- Cordarone and Activities Of Daily Living Impaired - 55 seconds ago
- Aciphex and Chronic Kidney Disease - a minute ago
- Penis Pain and drugs of ingredients of propafenone hydrochloride - 2 minutes ago
- Nystatin and Colonoscopy Abnormal - 2 minutes ago
- Venlafaxine Hydrochloride and Bortezomib drug interaction - 2 minutes ago
- Duavee and Zetia drug interaction - 2 minutes ago
- Amlodipine Besylate and Muscle Atrophy - 2 minutes ago
- Opsumit and Mycostatin drug interaction - 3 minutes ago